Dr. Claire Henchcliffe

Claire Henchcliffe, M.D., D.Phil. is the Vice Chair for Clinical Research in Neurology and the Director of the Parkinson’s and Movement Disorders Institute at Weill Cornell Medical Center in New York City. She read for her BA in Biochemistry and completed her graduate thesis at the University of Oxford in the UK. She then pursued post-doctoral training in genetics and neuroscience at the University of Cambridge, UK, and the University of California at Berkeley, California. Dr. Henchcliffe received her medical degree from the College of Physicians and Surgeons of Columbia University in New York City. She completed both her internship and residency in neurology, and subsequently a fellowship in movement disorders at Columbia Presbyterian Medical Center’s Neurological Institute. Her current research focuses on developing new treatments for Parkinson’s disease, and is clinical core leader of a NYSTEM-funded consortium to develop a cell-based therapy for this disorder. Her group have also developed a robust biomarker program, intended for improvement of clinical trial outcome measures. She has been an investigator and on the steering committees for multiple clinical trials in Parkinson’s disease, and is the Weill Cornell site Principal Investigator for the NIH-funded NeuroNEXT clinical trial network. Most recently, she serves as Medical Director of the Trial Innovation Unit, linking the NCATS-funded Weill Cornell Clinical and Translational Science Center to the newly formed national Trial Innovation Network. In addition to running a busy clinical practice specializing in movement disorders, she frequently teaches and writes about Parkinson’s disease and other neurodegenerative disorders.